ストックスクリーナーアプリを入手
120.67
1.10%
-1.34
アフターアワーズ：
120.67
Ligand Pharmaceuticals Inc (LGND) 最新ニュース
Rice Hall James & Associates LLC Sells 7,954 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Allspring Global Investments Holdings LLC Decreases Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Ligand Pharmaceuticals (LGND) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Sold by Acuitas Investments LLC - MarketBeat
Villere ST Denis J & Co. LLC Has $30.76 Million Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Allspring Global Investments Holdings LLC Cuts Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Acquired by Congress Asset Management Co. - MarketBeat
Louisiana State Employees Retirement System Increases Stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World
Yousif Capital Management LLC Has $771,000 Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Armenian Reporter
Yousif Capital Management LLC Has $771,000 Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Purchased by State of Alaska Department of Revenue - Defense World
Stephens Investment Management Group LLC Sells 5,914 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
abrdn plc Sells 72,509 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
SG Americas Securities LLC Purchases New Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Bought by Chicago Capital LLC - MarketBeat
Molluscum Contagiosum Market Expected to rise, 2034 | Verrica Pharmaceuticals, Novan and Ligand Pharmaceuticals, Veloce Biopharma, expected to drive market - Barchart
Ligand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
BlackRock, Inc. Reduces Stake in Ligand Pharmaceuticals Inc. - GuruFocus.com
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Hantz Financial Services Inc. Makes New Investment in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Looking Back On Ligand Pharmaceuticals (NASDAQ:LGND) - Seeking Alpha
Court Place Advisors LLC Sells 7,700 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Investors in Ligand Pharmaceuticals (NASDAQ:LGND) have seen decent returns of 53% over the past year - Simply Wall St
Ligand Pharmaceuticals (NASDAQ:LGND) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Burney Co. Grows Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
JPMorgan Chase & Co. Lowers Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Stock Position Lowered by JPMorgan Chase & Co. - Defense World
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Average Recommendation of “Buy” by Brokerages - Defense World
LGND (Ligand Pharmaceuticals) Debt-to-EBITDA : 0.54 (As of Sep. 2024) - GuruFocus.com
Ligand Pharmaceuticals (NASDAQ:LGND) Stock Price Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
Don't Ignore The Insider Selling In Ligand Pharmaceuticals - Simply Wall St
Principal Financial Group Inc. Boosts Stock Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World
Is Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Recent Price Movement Underpinned By Its Weak Fundamentals? - Simply Wall St
Jane Street Group LLC Sells 7,790 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World
Jane Street Group LLC Trims Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat
Octavio Espinoza Executes Sell Order: Offloads $244K In Ligand Pharmaceuticals Stock - Benzinga
Ligand Pharmaceuticals (NASDAQ:LGND) Updates FY 2024 Earnings Guidance - MarketBeat
Ligand Pharmaceuticals (NASDAQ:LGND) shareholders have earned a 59% return over the last year - Yahoo Finance
MML Investors Services LLC Makes New Investment in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World
Insider Sell Alert: Octavio Espinoza Sells Shares of Ligand Pharmaceuticals Inc (LGND) - GuruFocus.com
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) CFO Octavio Espinoza Sells 2,104 Shares - MarketBeat
Ligand Pharmaceuticals CFO Espinoza sells $244,850 in stock By Investing.com - Investing.com Canada
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):